Citable company snapshot
GILEAD SCIENCES, INC.'s latest SEC-sourced 2026-06-30 period shows $7.80B in revenue and $-10.50B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $7.80B | $6.96B | +12.1% |
| Gross Profit | Dec 31, 2020 | $5.93B | $5.35B | +10.8% |
| Operating Income | Jun 30, 2026 | $-10.39B | $2.59B | -501.9% |
| Net Income | Jun 30, 2026 | $-10.50B | $2.02B | -619.3% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $3.57B | $2.54B | +40.4% |
| Free Cash Flow (computed) | Jun 30, 2026 | $3.43B | $2.43B | +41.5% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 6, 2026; accession 0000882095-26-000031.
GILD company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.